Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | 4Q25 Preview · AI Server Expansion · Core & New Business Momentum / 2025-12-26 RESEARCH
  • [Research] Samsung Electro-Mechanics (009150) – SK Securities | MLCC Shortage Scenario · AI-Driven Portfolio Shift · Valuation Re-rating / 2025-11-24 RESEARCH
  • [Disclosure] Hyundai Motor (005380) – Decision on Convening General Meeting of Shareholders / 2026-02-25 Disclosures
  • [Disclosure] Samsung Electronics (005930) – Major Business Report (Decision on Treasury Stock Acquisition) / 2025-02-18 Semiconductors
  • [Disclosure] Hanwha Systems (272210) – Corporate Investor Relations (IR) Announcement / 2024-10-29 Disclosures
  • [Disclosure] SK Hynix (000660 / SKHY) – Decision on Business Acquisition (Correction) / 2025-03-17 Semiconductors
  • [Research] SK hynix (000660 / SKHY) – Eugene Investment | HBM Demand · AI Accelerator Diversification · Profitability / 2026-01-21 RESEARCH
  • [Disclosure] SK hynix (000660 / SKHY) – Provisional Financial Results (Fair Disclosure) / 2025-04-24 Semiconductors

[Disclosure] Celltrion (068270) – Change in Sales or Loss Structure by More Than 30% (15% for Large Corporations) / 2026-02-05

Posted on February 5, 2026August 6, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Celltrion reported record-high annual revenue of KRW 4.16T (+17.01%) and operating profit of KRW 1.17T (+137.49%) on a consolidated basis for FY2025, driven by expanding high-margin product sales and post-merger cost stabilization.

📊 [Key Disclosure Details & Financial Summary]

  • Disclosure Title: Change in Sales or Loss Structure by More Than 30% (15% for Large Corporations)
  • Financial Statement Type: Consolidated Financial Statements (K-IFRS)
  • Fiscal Period: January 1, 2025 ~ December 31, 2025 (FY2025)
  • Earnings Summary (Consolidated Basis / Unit: KRW):
    • Revenue: KRW 4,162,495,109,000 (approx. KRW 4.16T / +17.01% YoY)
    • Operating Profit: KRW 1,168,471,346,000 (approx. KRW 1.17T / +137.49% YoY)
    • Profit Before Income Tax: KRW 1,153,720,442,000 (approx. KRW 1.15T / +100.26% YoY)
    • Net Profit: KRW 1,031,483,789,000 (approx. KRW 1.03T / +146.25% YoY)
  • Financial Position (Consolidated Basis):
    • Total Assets: KRW 22,361,324,750,000 (approx. KRW 22.36T)
    • Total Liabilities: KRW 5,008,794,931,000 (approx. KRW 5.01T)
    • Total Equity: KRW 17,352,529,819,000 (approx. KRW 17.35T / Equity excluding non-controlling interests: KRW 17,208,474,472,000)
  • Key Drivers for Performance:
    • Revenue Growth: Continued steady global prescriptions for existing products and expanded sales of new high-margin products led to record annual sales.
    • Profit Growth: Dissipation of merger-related impacts, increased share of high-margin products, significant improvement in COGS ratio through production efficiency, and reduced fixed SG&A burden yielded record-high operating profit.
  • Board Resolution Date: February 5, 2026 (All 8 outside directors attended)
  • Note to Investors: Figures in this disclosure are based on internal management accounts prior to external audit completion and are subject to change upon final audit review.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of External Audit Report Submission and Finalized Financials

This disclosure details Celltrion’s provisional FY2025 financial results based on internal settlement data, making it important to confirm the finalized audited financial statements. Comparing the audited figures against the provisional numbers upon submission of the independent audit report ensures verification of final financial figures for the fiscal year. Finalized financial statements and audit opinions can be verified through upcoming ‘Submission of Audit Report’ disclosures or Annual Business Reports.

📢 Disclaimer & Source Information

Source: This content was newly generated and structured based on official data submitted to the Data Analysis, Retrieval and Transfer System (DART) of the Financial Supervisory Service.

Investment Risk Notice: This information is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Celltrion (068270) – Provisional Earnings Release (Consolidated Basis) / 2026-02-05
Next Post: [Disclosure] Hanmi Semiconductor (042700) – Preliminary Earnings Announcement (Fair Disclosure) / 2026-02-06

Related Posts

  • [Disclosure] Hanmi Semiconductor (042700) – Matters Related to Timely Disclosure Obligations (Fair Disclosure) / 2025-02-13 Semiconductors
  • [Disclosure] SK Square(402340) – Setting of Record Date or Period for Closure of Shareholder Register / 2024-07-03 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Performance / 2024-07-01 Disclosures
  • [Disclosure] Hana Micron (067310) – Additional Listing (Exercise of Stock Options) / 2024-05-03 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2026-07-13 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2024-09-02 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Provisional Sales Results (Fair Disclosure) / 2025-05-02 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Advance Notice of Financial Results Disclosure / 2026-07-09 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Equity Futures & Options Market Measures / 2025-03-27 Disclosures
  • [Disclosure] Wonik IPS (240810) – Advance Notice of Financial Results / 2025-04-22 Semiconductors
  • [Disclosure] Hanwha Ocean (042660) – (Correction) Signing of Single Sales/Supply Contract / 2025-02-27 Disclosures
  • [Disclosure] Celltrion (068270) – Advance Notice of Financial Results Disclosure / 2025-02-14 Disclosures
  • [Research] Samsung Electro-Mechanics (009150) – iM Securities | Automotive & Server Mix · Expanding MLCC Share · FC-BGA Upgrades / 2025-07-01 Uncategorized
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme